🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Metformin (open-label)

Found 556 matching trials

Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants

PHASE1

The purpose of this study is to evaluate the bioequivalence of metformin co...

Status

Completed

Location

Multiple Locations

Start Date

2014-08

Trial ID

NCT02221180

Treatments Being Tested

Canagliflozin and Metformin Immediate Release (IR) Fixed Dose Combination [FDC]Canagliflozin Metformin

A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects

PHASE1

The purpose of this study is to determine the effects of LX4211 and metform...

Status

Completed

Location

Lexicon Investigational Site

Start Date

2011-02

Trial ID

NCT01292993

Treatments Being Tested

400 mg LX4211 1000 mg metformin

Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition

PHASE1

This study is a phase 1, open label, randomized, three-way crossover, singl...

Status

Unknown

Location

Clinical Investigation Centre, University Malaya Medical Centre

Start Date

2019-08-21

Trial ID

NCT04161404

Treatments Being Tested

Brand name: Andrographis paniculata (Shine Hempedu Bumi) 1000mg capsules Brand name: Andrographis paniculata (Shine Hempedu Bumi) 2000mg Metformin (Glucophage) 1000mg

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

PHASE2

DiObex Inc. is developing an experimental drug (DIO-902) that is made up of...

Status

Terminated

Location

Dr. Terence Hart

Start Date

2008-01

Trial ID

NCT00622089

Treatments Being Tested

DIO-902 DIO-902 DIO-902

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

PHASE1

This trial is conducted in Europe and Asia. The aim of the trial is to inve...

Status

Completed

Location

Novo Nordisk Investigational Site

Start Date

2013-12-17

Trial ID

NCT02022254

Treatments Being Tested

semaglutide placebo metformin warfarin

A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.

PHASE1

Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...

Status

Completed

Location

Jeonbuk National University Hospital

Start Date

2026-01-09

Trial ID

NCT07399470

Treatments Being Tested

Test drug: Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg Reference drug: Gemigliptin (Zemiglo) 50mg, Dapagliflozin/metformin (Xigduo XR) 10/1000 mg

A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

PHASE3

The study is being conducted to evaluate the efficacy and safety of HRS9531...

Status

Completed

Location

Zhu Xianyi Memorial Hospital,Tianjin Medical University

Start Date

2024-10-31

Trial ID

NCT06649344

Treatments Being Tested

HRS9531 Injection Semaglutide Injection

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of a fixed dose...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01463228

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

PHASE3

This is a randomized, open-label, crossover study to determine the effect o...

Status

Completed

Location

Multiple Locations

Start Date

2014-06

Trial ID

NCT02276274

Treatments Being Tested

SYR-322-MET

Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma

PHASE2

This phase II trial study assessing the activity of metformin when given to...

Status

Terminated

Location

UOPECCAN - Hospital do Câncer de Cascavel

Start Date

2017-01

Trial ID

NCT02967276

Treatments Being Tested

Metformin XR Dexamethasone

Previous Next